3,3′-[6,6′-bi-1H-Benzimidazole]-2,2′-diylbis-benzenamine

3,3′-[6,6′-bi-1H-Benzimidazole]-2,2′-diylbis-benzenamine Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354 +1-00000000000
Email: marketing@targetmol.com
Products Intro: Product Name:DDRI-18;DDRI18;DDRI 18
CAS:4402-18-0
Package:100 mg;500 mg Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: Sigma-Aldrich  
Tel: 021-61415566 800-8193336
Email: orderCN@merckgroup.com
Products Intro: Product Name:DDRI-18
CAS:4402-18-0
Purity:>=98% (HPLC) Package:5MG Remarks:SML0710-5MG
Company Name: Tianjin Kailiqi Biotechnology Co., Ltd.  
Tel: 15076683720
Email: klq@cw-bio.com
Products Intro: Product Name:DDRI-18
CAS:4402-18-0
Purity:大于98% Package:1g,5g,10g,25g根据客户需要分装 Remarks:Not For Human Use, Lab Use Only.
Company Name: TargetMol Chemicals Inc.  
Tel: 4008200310
Email: marketing@tsbiochem.com
Products Intro: Product Name:DDRI-18;DDRI18,DDRI 18
CAS:4402-18-0
Purity:98% Package:5 mg
Company Name: Yantai Lianhua Technology Co., Ltd  
Tel: 15552437730
Email: 1701654643@qq.com
Products Intro: Product Name:3,3′-[6,6′-bi-1H-Benzimidazole]-2,2′-diylbis-benzenamine
CAS:4402-18-0
Purity:95%+ Package:50G;100G
3,3′-[6,6′-bi-1H-Benzimidazole]-2,2′-diylbis-benzenamine Basic information
Product Name:3,3′-[6,6′-bi-1H-Benzimidazole]-2,2′-diylbis-benzenamine
Synonyms:DDRI-18;3,3′-[6,6′-bi-1H-Benzimidazole]-2,2′-diylbis-benzenamine;DDRI18,DDRI 18;Benzenamine, 3,3'-[6,6'-bi-1H-benzimidazole]-2,2'-diylbis-
CAS:4402-18-0
MF:C26H20N6
MW:416.48
EINECS:
Product Categories:
Mol File:4402-18-0.mol
3,3′-[6,6′-bi-1H-Benzimidazole]-2,2′-diylbis-benzenamine Structure
3,3′-[6,6′-bi-1H-Benzimidazole]-2,2′-diylbis-benzenamine Chemical Properties
Melting point 297-299 °C
Boiling point 835.8±75.0 °C(Predicted)
density 1.382±0.06 g/cm3(Predicted)
storage temp. 2-8°C
solubility DMSO: soluble10mg/mL
form powder
pka10.77±0.10(Predicted)
color white to beige
Safety Information
Hazard Codes Xi
Risk Statements 36/37/38
Safety Statements 26
WGK Germany 3
MSDS Information
3,3′-[6,6′-bi-1H-Benzimidazole]-2,2′-diylbis-benzenamine Usage And Synthesis
Biochem/physiol ActionsDDRI-18 (DNA Damage Response Inhibitor-18) inhibits nonhomologous end-joining (NHEJ) DNA repair following double strand DNA breaks induced by ionizing radiation, and enhances the effects of DNA-damaging cancer drugs like etoposide, camptothecin and doxorubicin.
3,3′-[6,6′-bi-1H-Benzimidazole]-2,2′-diylbis-benzenamine Preparation Products And Raw materials
Tag:3,3′-[6,6′-bi-1H-Benzimidazole]-2,2′-diylbis-benzenamine(4402-18-0) Related Product Information